The Board of Directors of AstraZeneca Pharma India Limited based on the recommendations of Nomination and Remuneration Committee, approved the appointment of Ms. Shilpa Shridhar Divekar as an Additional Director (Non-executive & Independent) of the Company with effect from December 29, 2021. Ms. Shilpa Shridhar Divekar has over two decades of rich experience across consulting and food & agriculture sectors. As part of her leadership journey, she led Regional Business Strategy for Asia Pacific and co-led Global Smallholder Strategy at Bayer CropScience. She served as the Chief Executive Officer of Monsanto India from 2014 to 2018 and was also responsible as Managing Director of the publicly listed entity in India. Prior to her 12 years stint at Bayer and Monsanto, she was the Head of Strategy & Business Development for Bunge India, a US headquartered multinational involved in oilseeds, commodity trading & foods.